SPBC713.13 is produced via recombinant expression in heterologous systems, with notable variations in host organisms and purification strategies:
Recombinant SPBC713.13 is typically purified via affinity chromatography (e.g., nickel-NTA for His-tagged proteins) or ion-exchange methods .
While SPBC713.13 lacks a defined role, interaction studies and genetic network analyses provide indirect clues:
Protein interactions: STRING database analysis identifies SPBC713.13 as a predicted partner of zas1 (zinc finger protein) and other uncharacterized proteins (e.g., SPBC713.14c) with interaction scores >0.6 . These associations suggest potential involvement in:
Genetic context: No direct functional studies on SPBC713.13 have been reported, but its genetic neighborhood (e.g., SPBC713.14c) implies conserved synteny in S. pombe .
SPBC713.13, like other transmembrane proteins, poses challenges in recombinant production:
Low solubility: Hydrophobic transmembrane domains may require detergents (e.g., DDM) for solubilization .
Structural ambiguity: Absence from PDB_TM (a database of transmembrane proteins with resolved structures) indicates no high-resolution structural data .
Functional validation: Lack of enzymatic assays or phenotypic readouts complicates activity assessment .
Commercially available SPBC713.13 variants differ in formulation and utility:
| Product Code | Supplier | Host | Sequence | Purity | Tags | Applications |
|---|---|---|---|---|---|---|
| MBS1024203 | MyBioSource | E. coli/Yeast | Full (1–108 aa) | ≥85% | N-terminal (variable) | ELISA, Western blot, structural studies |
| CSB-EP520745SXV1 | Cusabio | E. coli | Partial | >85% | Unspecified | ELISA, protein interaction studies |
| CSB-YP520745SXV1 | Cusabio | Yeast | Partial | >85% | Unspecified | Functional assays, secretion studies |
Note: Partial sequences may exclude critical transmembrane domains .
The protein SPBC713.13, annotated as a putative uncharacterized transmembrane protein in Schizosaccharomyces pombe, is believed to play a role in cellular processes that remain largely undefined. Transmembrane proteins are typically involved in cell signaling, transport, or structural functions within the membrane. In S. pombe, which serves as a model organism for eukaryotic biology, transmembrane proteins often participate in maintaining cellular homeostasis, responding to environmental stimuli, and mediating intracellular communication. The uncharacterized nature of SPBC713.13 suggests that its specific functions have not yet been elucidated through experimental studies, making it an intriguing target for further investigation .
Research into such proteins often begins with bioinformatic analyses to predict structural domains and potential functional motifs based on sequence homology. For SPBC713.13, computational tools could help hypothesize its role by identifying conserved regions that align with known protein families.
To experimentally verify the function of SPBC713.13, researchers can employ a combination of genetic, biochemical, and cell biology approaches:
Gene Knockout or Knockdown Studies: Using CRISPR-Cas9 or RNA interference (RNAi), researchers can disrupt the gene encoding SPBC713.13 in S. pombe. Observing phenotypic changes in response to gene disruption can provide clues about its biological role.
Overexpression Systems: Cloning the gene into an expression vector and introducing it into S. pombe or a heterologous system allows researchers to study the effects of overexpression on cellular physiology.
Protein Localization Studies: Employing fluorescent tagging (e.g., GFP fusion) enables visualization of SPBC713.13 within cells to determine its subcellular localization.
Protein-Protein Interaction Assays: Techniques such as co-immunoprecipitation or yeast two-hybrid screening can identify interacting partners of SPBC713.13, shedding light on its functional pathways.
Functional Complementation: Introducing the SPBC713.13 gene into mutant strains lacking homologous proteins may reveal whether it can rescue specific phenotypes.
These approaches require careful experimental design to control for off-target effects and ensure reproducibility .
Studying uncharacterized transmembrane proteins presents several challenges:
Structural Complexity: Transmembrane domains are hydrophobic and difficult to solubilize, complicating purification and structural analysis.
Functional Redundancy: Proteins with overlapping functions may mask phenotypic effects in knockout studies.
Lack of Homology: Limited sequence similarity with characterized proteins can hinder functional predictions.
Experimental Artifacts: Overexpression or tagging may alter protein behavior or localization.
To address these challenges, researchers often use advanced techniques such as cryo-electron microscopy for structural studies or mass spectrometry-based proteomics to identify interaction networks .
Bioinformatics tools play a crucial role in characterizing unstudied proteins like SPBC713.13:
Sequence Analysis:
BLAST (Basic Local Alignment Search Tool) identifies homologous sequences in other organisms.
Pfam and SMART databases predict functional domains.
Structural Prediction:
AlphaFold provides high-confidence structural models based on sequence data.
TMHMM predicts transmembrane helices.
Functional Annotation:
STRING database identifies potential interaction networks.
GO (Gene Ontology) enrichment analysis links the protein to biological processes.
Phylogenetic Analysis:
MEGA software constructs evolutionary trees to trace homologs across species.
The choice of recombinant expression system significantly influences the study outcomes for SPBC713.13:
Host Organism: While S. pombe is ideal for studying native functions, heterologous systems like Escherichia coli or insect cells may be used for large-scale protein production.
Post-Translational Modifications (PTMs): Eukaryotic systems are preferred if PTMs such as glycosylation are critical for function.
Expression Levels: Overexpression can lead to misfolding or aggregation; optimizing expression conditions is essential.
Purification Tags: Fusion tags (e.g., His-tag) facilitate purification but may interfere with activity or localization.
Careful optimization of these parameters ensures that recombinant SPBC713.13 retains its native properties .
Experimental designs should integrate multiple approaches:
Phenotypic Screening:
Assess growth rates, stress responses, and morphological changes in mutants lacking SPBC713.13 under various conditions.
Omics Approaches:
Transcriptomics reveals gene expression changes upon deletion or overexpression.
Proteomics identifies downstream effectors and interaction partners.
Synthetic Genetic Array (SGA):
Comparative Studies:
Analyze homologous proteins in related species to infer conserved functions.
Statistical analysis ensures that observed effects are significant and reproducible .
Genetic interaction studies reveal how SPBC713.13 interacts with other genes:
Epistasis Analysis: Determines whether SPBC713.13 acts upstream or downstream of interacting genes.
Suppressor Screens: Identify mutations that rescue phenotypes caused by loss of SPBC713.13.
Synthetic Lethality: Highlights essential pathways where redundancy compensates for its absence.
These approaches provide insights into the broader network within which SPBC713.13 operates .
Understanding SPBC713.13 has implications beyond basic biology:
Modeling Human Diseases:
Homologs in humans may be linked to disease pathways; studying their yeast counterparts provides mechanistic insights.
Drug Discovery:
Targeting pathways involving SPBC713.13 could yield novel therapeutics.
Biotechnology Applications:
Engineering transmembrane proteins for industrial processes benefits from foundational knowledge about their structure-function relationships.
Future research may uncover additional applications as more is learned about this enigmatic protein .